Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
CAPS STERILE ADMIXTURE is a federal award for W40m Mrco Pacific held by Central Admixture Pharmacy Services, Inc. Estimated value $113K ($0 obligated). Current period of performance ends Sep 30, 2026. Place of performance: IRVINE CA.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordCentral Admixture Pharmacy Services, Inc — $5.4M obligated across 70 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0225FA064?
W81K0225FA064 (CAPS sterile admixture) is a W40m Mrco Pacific award with a potential value of $113K, currently held by Central Admixture Pharmacy Services, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0225FA064?
W40m Mrco Pacific awarded W81K0225FA064 to Central Admixture Pharmacy Services, Inc (potential $113K).
Who is the incumbent on W81K0225FA064?
Central Admixture Pharmacy Services, Inc is the incumbent with $5.4M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Central Admixture Pharmacy Services, Inc’s W81K0225FA064 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.